177 related articles for article (PubMed ID: 17849011)
1. Role of ENPP1 on adipocyte maturation.
Liang J; Fu M; Ciociola E; Chandalia M; Abate N
PLoS One; 2007 Sep; 2(9):e882. PubMed ID: 17849011
[TBL] [Abstract][Full Text] [Related]
2. Metabolic consequences of ENPP1 overexpression in adipose tissue.
Pan W; Ciociola E; Saraf M; Tumurbaatar B; Tuvdendorj D; Prasad S; Chandalia M; Abate N
Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E901-11. PubMed ID: 21810932
[TBL] [Abstract][Full Text] [Related]
3. Adipose Tissue Insulin Resistance in Gestational Diabetes.
Tumurbaatar B; Poole AT; Olson G; Makhlouf M; Sallam HS; Thukuntla S; Kankanala S; Ekhaese O; Gomez G; Chandalia M; Abate N
Metab Syndr Relat Disord; 2017 Mar; 15(2):86-92. PubMed ID: 28080219
[TBL] [Abstract][Full Text] [Related]
4. Adipose tissue dysfunction in humans: a potential role for the transmembrane protein ENPP1.
Chandalia M; Davila H; Pan W; Szuszkiewicz M; Tuvdendorj D; Livingston EH; Abate N
J Clin Endocrinol Metab; 2012 Dec; 97(12):4663-72. PubMed ID: 23012391
[TBL] [Abstract][Full Text] [Related]
5. ENPP1 gene, insulin resistance and related clinical outcomes.
Bacci S; De Cosmo S; Prudente S; Trischitta V
Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):403-9. PubMed ID: 17563456
[TBL] [Abstract][Full Text] [Related]
6. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities.
Goldfine ID; Maddux BA; Youngren JF; Reaven G; Accili D; Trischitta V; Vigneri R; Frittitta L
Endocr Rev; 2008 Feb; 29(1):62-75. PubMed ID: 18199690
[TBL] [Abstract][Full Text] [Related]
7. Role of GALNT2 in the modulation of ENPP1 expression, and insulin signaling and action: GALNT2: a novel modulator of insulin signaling.
Marucci A; Cozzolino F; Dimatteo C; Monti M; Pucci P; Trischitta V; Di Paola R
Biochim Biophys Acta; 2013 Jun; 1833(6):1388-95. PubMed ID: 23500900
[TBL] [Abstract][Full Text] [Related]
8. The hepatic ectonucleotide pyrophosphatase/phosphodiesterase 1 gene mRNA abundance is reduced by insulin and induced by dexamethasone.
Ma H; Wang P; Jin D; Jia T; Mao H; Zhang J; Zhao S
Braz J Med Biol Res; 2018 Mar; 51(4):e6980. PubMed ID: 29513794
[TBL] [Abstract][Full Text] [Related]
9. Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression.
Boucher J; Quilliot D; Pradères JP; Simon MF; Grès S; Guigné C; Prévot D; Ferry G; Boutin JA; Carpéné C; Valet P; Saulnier-Blache JS
Diabetologia; 2005 Mar; 48(3):569-77. PubMed ID: 15700135
[TBL] [Abstract][Full Text] [Related]
10. Expression of ectonucleotide pyrophosphate phosphodiesterase and peroxisome proliferator activated receptor gamma in morbidly obese patients.
Brody F; Hill S; Celenski S; Kar R; Kluk B; Pinzone J; Fu S
Surg Endosc; 2007 Jun; 21(6):941-4. PubMed ID: 17287921
[TBL] [Abstract][Full Text] [Related]
11. The role of ENPP1/PC-1 in osteoinduction by calcium phosphate ceramics.
Othman Z; Fernandes H; Groot AJ; Luider TM; Alcinesio A; Pereira DM; Guttenplan APM; Yuan H; Habibovic P
Biomaterials; 2019 Jul; 210():12-24. PubMed ID: 31048198
[TBL] [Abstract][Full Text] [Related]
12. Role of somatomedin-B-like domains on ENPP1 inhibition of insulin signaling.
Dimatteo C; Marucci A; Palazzo A; Cisternino C; Marsano RM; Trischitta V; Di Paola R
Biochim Biophys Acta; 2013 Mar; 1833(3):552-8. PubMed ID: 23098853
[TBL] [Abstract][Full Text] [Related]
13. Editorial: The pleiotropic effect of the ENPP1 (PC-1) gene on insulin resistance, obesity, and type 2 diabetes.
Prudente S; Trischitta V
J Clin Endocrinol Metab; 2006 Dec; 91(12):4767-8. PubMed ID: 17148571
[No Abstract] [Full Text] [Related]
14. Mechanisms of disease: Ectonucleotide pyrophosphatase phosphodiesterase 1 as a 'gatekeeper' of insulin receptors.
Abate N; Chandalia M; Di Paola R; Foster DW; Grundy SM; Trischitta V
Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):694-701. PubMed ID: 17143316
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of the bone mineralization inhibitor NPP1 protects mice against obesity and diabetes.
Huesa C; Zhu D; Glover JD; Ferron M; Karsenty G; Milne EM; Millan JL; Ahmed SF; Farquharson C; Morton NM; MacRae VE
Dis Model Mech; 2014 Dec; 7(12):1341-50. PubMed ID: 25368121
[TBL] [Abstract][Full Text] [Related]
16. Resistin affects lipid metabolism during adipocyte maturation of 3T3-L1 cells.
Ikeda Y; Tsuchiya H; Hama S; Kajimoto K; Kogure K
FEBS J; 2013 Nov; 280(22):5884-95. PubMed ID: 24034627
[TBL] [Abstract][Full Text] [Related]
17. Association of ENPP1 (PC-1) K121Q polymorphism with obesity-related parameters in subjects with metabolic syndrome.
González-Sánchez JL; Zabena C; Martínez-Larrad MT; Martínez-Calatrava MJ; Pérez-Barba M; Serrano-Ríos M
Clin Endocrinol (Oxf); 2008 May; 68(5):724-9. PubMed ID: 17986276
[TBL] [Abstract][Full Text] [Related]
18. The role of HSP70 on ENPP1 expression and insulin-receptor activation.
Marucci A; Miscio G; Padovano L; Boonyasrisawat W; Florez JC; Doria A; Trischitta V; Paola RD
J Mol Med (Berl); 2009 Feb; 87(2):139-144. PubMed ID: 19083193
[TBL] [Abstract][Full Text] [Related]
19. ENPP1 variants and haplotypes predispose to early onset obesity and impaired glucose and insulin metabolism in German obese children.
Böttcher Y; Körner A; Reinehr T; Enigk B; Kiess W; Stumvoll M; Kovacs P
J Clin Endocrinol Metab; 2006 Dec; 91(12):4948-52. PubMed ID: 16968801
[TBL] [Abstract][Full Text] [Related]
20. Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity.
Chin CN; Dallas-Yang Q; Liu F; Ho T; Ellsworth K; Fischer P; Natasha T; Ireland C; Lu P; Li C; Wang IM; Strohl W; Berger JP; An Z; Zhang BB; Jiang G
Eur J Pharmacol; 2009 Mar; 606(1-3):17-24. PubMed ID: 19374858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
